You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ISOPROTERENOL HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for isoproterenol hydrochloride and what is the scope of patent protection?

Isoproterenol hydrochloride is the generic ingredient in six branded drugs marketed by 3M, Alpharma Us Pharms, Sanofi Aventis Us, Abbott, Abraxis Pharm, Am Regent, Amneal, Amphastar Pharms Inc, Amring Pharms, Avet Lifesciences, Baxter Hlthcare, Cipla, Eugia Pharma, Hikma, Hospira, Intl Medication, Micro Labs, Nexus, Norvium Bioscience, Penn Life, Somerset Theraps Llc, Zydus Pharms, Bausch, Lilly, Armour Pharm, DEY, Parke Davis, and Fisons, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for isoproterenol hydrochloride. Eleven suppliers are listed for this compound.

Summary for ISOPROTERENOL HYDROCHLORIDE
US Patents:0
Tradenames:6
Applicants:28
NDAs:35
Drug Master File Entries: 14
Finished Product Suppliers / Packagers: 11
Raw Ingredient (Bulk) Api Vendors: 118
Clinical Trials: 25
Patent Applications: 1,374
What excipients (inactive ingredients) are in ISOPROTERENOL HYDROCHLORIDE?ISOPROTERENOL HYDROCHLORIDE excipients list
DailyMed Link:ISOPROTERENOL HYDROCHLORIDE at DailyMed
Recent Clinical Trials for ISOPROTERENOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of AlbertaPhase 1
Ningbo No. 1 HospitalPhase 4
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4

See all ISOPROTERENOL HYDROCHLORIDE clinical trials

Pharmacology for ISOPROTERENOL HYDROCHLORIDE
Drug Classbeta-Adrenergic Agonist
Mechanism of ActionAdrenergic beta-Agonists

US Patents and Regulatory Information for ISOPROTERENOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 211864-001 Feb 9, 2021 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083283-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sanofi Aventis Us ISUPREL isoproterenol hydrochloride SOLUTION;INHALATION 006327-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
3m DUO-MEDIHALER isoproterenol hydrochloride; phenylephrine bitartrate AEROSOL, METERED;INHALATION 013296-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.